Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Angeliki Stefanou"'
Autor:
Eleni Lalou, Vasileios I. Telonis, Anna Zannou, Pantelis Tsirkinidis, Alexander Kanellopoulos, Angeliki Stefanou, John Meletis, Evangelos Terpos, Marie-Christine Kyrtsonis, Panayiotis Panayiotidis, Athanasios Papatheodorou, Zacharoula Galani, Georgios Boutsikas, Maria K. Angelopoulou, Anastasia Meletiou, Theodoros P. Vassilakopoulos, Nora-Athina Viniou, Panayiotis Tsirigotis, Panayiotis Tsaftaridis
Publikováno v:
European Journal of Haematology. 100:131-139
OBJECTIVES As the interaction between hematopoietic stem cells (HSCs) and endosteal and endothelial niches in HSCs homing is essential, we aimed to study bone turnover and angiogenesis in 29 patients with lymphoma/multiple myeloma undergoing hematopo
The evolution of imipenem disk-diffusion susceptibility results of 2652 strains of Klebsiella pneumoniae and 7596 Escherichia coli isolated during the period 2000-2005 were analysed. Screening for production of metallo-beta-lactamases was performed u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::37eb29fc2f9eb9854d4ed098aa3afcce
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3116079
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3116079
Autor:
Maria K. Angelopoulou, Efstathia Staikou, Georgios Xanthopoulidis, Eleni Variami, Konstantinos Anargyrou, George Georgiou, Danai Palaiologou, Konstantinos Tsatalas, Vassiliki Pappi, Dionysis Kolokythopoulos, Theodoros P. Vassilakopoulos, Eleni Plata, Ioannis Korantzis, Elissavet Vervesou, Argiris Symeonidis, Maria Papaioannou, Maria Dimou, Maria Protopapa, Konstantina Reppa, Charis Matsouka, Eleni Poumbouridou, Dimitra Liapi, Marie-Christine Kyrtsonis, Theodore Marinakis, Konstantinos Tsionos, Panayiotis Panayiotidis, Angeliki Stefanou, Ioannis Klonizakis, Dimitra Gougopoulou, Paraskevi Roussou, Zacharoula Galani, Eirini Katodritou, Nora Vyniou, Maria Roumelioti, Gerasimos Pangalis
Publikováno v:
Blood. 118:4446-4446
Abstract 4446 First-line therapy for Chronic Myeloid Leukemia (CML) is based on the tyrosine kinase inhibitor Imatinib, according to the published recommendations of the European Leukemia Net (Baccarani et al, JCO, 2009). CML patients that achieve th